Differential expression of PD-L1, PD-L2 and inflammasome related proteins (NLRP3, ASC, and Caspase-1) in oral squamous cell carcinoma, lymph node metastases, and benign lesions.

This study investigates the expression of immune checkpoint proteins (PD-L1 and PD-L2) and inflammasome components (NLRP3, ASC, and Caspase-1) in oral lesions, including squamous cell carcinoma (SCC), metastases, leukoplakia, and benign conditions. Immunohistochemical analysis was performed on tissue samples from 151 patients to evaluate expression patterns and assess their diagnostic and prognostic potential. PD-L1 and PD-L2 were significantly overexpressed in SCC and metastases compared to benign lesions with IRS factor (immunoreactive score) (p = 0.003) and (p = 0.000002), indicating their roles in immune evasion and tumor progression. NLRP3 and ASC demonstrated associations with inflammation-driven carcinogenesis, with variations linked to tumor localization. However, none of the biomarkers showed significant prognostic value for disease progression. These findings highlight the potential diagnostic utility of these proteins while underscoring the need for further research to establish reliable clinical biomarkers in oral SCC.

• Publication year

  2025

• Venue

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jcms.2025.10.002PMID 41224569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in biomarker detection of oral squamous cell carcinoma

  2025cited by this paper
• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• Exploring the prognostic landscape of oral squamous cell carcinoma through mitochondrial damage-related genes

  2024cited by this paper
• The predictive role of PD-L1 in head and neck cancer: A systematic review and meta-analysis.

  2024cited by this paper
• Divergent functions of NLRP3 inflammasomes in cancer: a review

  2023cited by this paper
• Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy.

  2023cited by this paper
• MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures

  2023cited by this paper
• Tumor microenvironment and immunotherapy of oral cancer

  2022cited by this paper
• Hallmarks of Resistance to Immune-Checkpoint Inhibitors

  2022cited by this paper
• Osteosarcoma: a review of current and future therapeutic approaches

  2021cited by this paper
• NLRP3 inflammasome activation triggers gasdermin D–independent inflammation

  2021cited by this paper
• NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression

  2021cited by this paper
• PD1 expression and correlation with its ligands in oral cancer specimens and peripheral blood.

  2020cited by this paper
• Cisplatin‐induced programmed cell death ligand‐2 expression is associated with metastasis ability in oral squamous cell carcinoma

  2020cited by this paper
• ASC modulates HIF-1α stability and induces cell mobility in OSCC

  2020cited by this paper
• The NLRP3 inflammasome: molecular activation and regulation to therapeutics

  2019cited by this paper
• Prognostic significance of PD‐L2 expression in patients with oral squamous cell carcinoma—A comparison to the PD‐L1 expression profile

  2019cited by this paper
• NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma

  2017cited by this paper
• The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment.

  2016cited by this paper
• High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma

  2015cited by this paper
• Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression

  2015cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Outcome analysis of patients with oral cavity cancer and extracapsular spread in neck lymph nodes.

  2011cited by this paper
• B7-H1 Expression on Non-Small Cell Lung Cancer Cells and Its Relationship with Tumor-Infiltrating Lymphocytes and Their PD-1 Expression

  2004cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper

• No citing papers are available for this paper.